Bard Avaulta Mesh Lawsuit

October 14, 2012

A California woman and her husband were recently awarded a $5.5 million settlement for a lawsuit that they filed against medical device company C. R. Bard claiming that their Avaulta mesh product was responsible for serious injuries as well as a sharp decline in her quality of life. The woman had the Avaulta mesh implanted in order to help with bladder leakage problems that she experienced while running, but she soon found herself with a new and much more serious set of problems. The Bard Avaulta mesh punctured her colon and surrounding body tissue began to grow through openings in the mesh. To date, she has had eight corrective surgeries and will require more. This Bard Avaulta mesh lawsuit claimed that C. R. Bard was aware of the safety issues of its product, but negligently chose to market it regardless.

What is Bard Avaulta Mesh?

Bard Avaulta Mesh is a type of surgical device used to repair weakened tissue in the conditions of pelvic organ prolapse as well as stress urinary incontinence. For pelvic organ prolapse the mesh is used to reinforce the vaginal wall in order to prevent the bulging of pelvic organs. In stress urinary incontinence, the mesh is used to support the urethra in order to prevent involuntary bladder leakage during physical activity. Although Bard Avaulta mesh and other mesh products are presented as a permanent solution, they have been found to present new risks that are not present in other treatment options. Lawsuit claims have been filed against Bard, as well as the following mesh manufacturers:

  • Boston Scientific
  • American Medical Systems
  • Ethicon (a Johnson & Johnson subsidiary)

As early as 2008, the United States Food and Drug Administration was issuing warnings that surgery with vaginal mesh (including Bard Avaulta) posed serious risks of complications including infection, mesh erosion through vaginal tissue, neuromuscular problems, and even recurrence of pelvic organ prolapse or stress urinary incontinence. Many of the complications linked to Bard Avaulta mesh require additional revision surgeries, hospitalization, blood transfusions, or IV therapy. In 2011, the FDA amended their previous warning in order to alert the public the mesh injuries are not rare and that other treatment options should be considered.

File a Bard Avaulta Mesh Lawsuit: Free Attorney Consultation

Were you treated with C. R. Bard’s Avaulta mesh for pelvic organ prolapse or stress urinary incontinence? Did you experience serious mesh related complications following your initial surgery? If so, contact the Willis Law Firm today for a free and confidential Bard Avaulta transvaginal mesh lawsuit case evaluation conducted by one of our compassionate and caring female associates. You may be legally entitled for financial compensation for your pain and suffering. Presently, we are reviewing mesh lawsuit cases in all fifty states, and all Avaulta clients are represented on a contingency fee basis.

© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.